Zhaoqi Liu
Cited by
Cited by
Clonal evolution of glioblastoma under therapy
J Wang, E Cazzato, E Ladewig, V Frattini, DIS Rosenbloom, S Zairis, ...
Nature genetics 48 (7), 768-776, 2016
Spatiotemporal genomic architecture informs precision oncology in glioblastoma
JK Lee, J Wang, JK Sa, E Ladewig, HO Lee, IH Lee, HJ Kang, ...
Nature genetics 49 (4), 594-599, 2017
Inferring causal molecular networks: empirical assessment through a community-based effort
SM Hill, LM Heiser, T Cokelaer, M Unger, NK Nesser, DE Carlin, Y Zhang, ...
Nature Methods 13, 310–318, 2016
Database resources of the national genomics data center, china national center for bioinformation in 2022
Nucleic Acids Research 50 (D1), D27-D38, 2022
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
JK Lee, Z Liu, JK Sa, S Shin, J Wang, M Bordyuh, HJ Cho, O Elliott, T Chu, ...
Nature genetics 50 (10), 1399-1411, 2018
iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4
D Chen, B Chu, X Yang, Z Liu, Y Jin, N Kon, R Rabadan, X Jiang, ...
Nature Communications 12 (1), 3644, 2021
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors
M Djurec, O Graña, A Lee, K Troulé, E Espinet, L Cabras, C Navas, ...
Proceedings of the National Academy of Sciences 115 (6), E1147-E1156, 2018
Breast tumor subgroups reveal diverse clinical prognostic power
Z Liu, XS Zhang, S Zhang
Scientific reports 4 (1), 4002, 2014
Disease-causing mutations in SF3B1 alter splicing by disrupting interaction with SUGP1
J Zhang, AM Ali, YK Lieu, Z Liu, J Gao, R Rabadan, A Raza, S Mukherjee, ...
Molecular cell 76 (1), 82-95. e7, 2019
Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization
Z Liu, A Yoshimi, J Wang, H Cho, S Chun-Wei Lee, M Ki, L Bitner, T Chu, ...
Cancer discovery 10 (6), 806-821, 2020
Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma
L Arnes, Z Liu, J Wang, C Maurer, I Sagalovskiy, M Sanchez-Martin, ...
Gut 68 (3), 499-511, 2019
Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK–STAT pathway
Z Liu, I Filip, K Gomez, D Engelbrecht, S Meer, PN Lalloo, P Patel, ...
Blood cancer discovery 1 (1), 112-125, 2020
SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes
YK Lieu, Z Liu, AM Ali, X Wei, A Penson, J Zhang, X An, R Rabadan, ...
Proceedings of the National Academy of Sciences 119 (1), e2111703119, 2022
Tumor characterization and stratification by integrated molecular profiles reveals essential pan-cancer features
Z Liu, S Zhang
BMC genomics 16, 1-12, 2015
Pan-cancer analysis identifies mutations in SUGP1 that recapitulate mutant SF3B1 splicing dysregulation
Z Liu, J Zhang, Y Sun, TE Perea-Chamblee, JL Manley, R Rabadan
Proceedings of the National Academy of Sciences 117 (19), 10305-10312, 2020
Mutant SF3B1 promotes AKT- and NF-κB–driven mammary tumorigenesis
B Liu, Z Liu, S Chen, M Ki, C Erickson, JS Reis-Filho, BH Durham, ...
The Journal of Clinical Investigation 131 (1), 2021
Toward a systematic understanding of cancers: a survey of the pan-cancer study
Z Liu, S Zhang
Frontiers in genetics 5, 194, 2014
NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data
M Zou, Z Liu, XS Zhang, Y Wang
Bioinformatics 31 (20), 3330-3338, 2015
Computing the role of alternative splicing in cancer
Z Liu, R Rabadan
Trends in cancer 7 (4), 347-358, 2021
Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target
S Han, H Shin, JK Lee, Z Liu, R Rabadan, J Lee, J Shin, C Lee, H Yang, ...
Experimental & Molecular Medicine 51 (12), 1-11, 2019
The system can't perform the operation now. Try again later.
Articles 1–20